Open AccessThe prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naïve patients with chronic lymphocytic leukemia
Author(s) -
Sinem Nihal Esatoğlu,
Dilek Keskin,
Ahmet Emre Eşkazan,
Tuğrul Elverdi,
Ayşe Salihoğlu,
Muhlis Cem Ar,
Şeniz Öngören,
Zafer Başlar,
Yıldız Aydın,
Hafize Uzun,
Teoman Soysal
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2004-282
Subject(s) - medicine , chemotherapy , chronic lymphocytic leukemia , gastroenterology , confidence interval , leukemia , oncology , immunology
A proliferation-inducing ligand (APRIL) has been investigated as a prognostic marker in chronic lymphocytic leukemia (CLL) patients. However, there is no cut-off level for serum APRIL (sAPRIL) levels that predict time to treatment in CLL patients.